From: The immune response to sub-clinical mastitis is impaired in HIV-infected women
Characteristics | HIV+ women (n = 40) Median [range] or N (%) | HIV− women (n = 43) Median [range] or N (%) |
---|---|---|
Maternal age at delivery (years) | 26 [17–39] | 23 [17–46] |
Previous pregnancies (at least one) | 30 (75.0%) | 25 (58.1%) |
Mode of delivery | ||
Vaginal | 36 (90.0%) | 38 (88.4%) |
Caesarean | 4 (10.0%) | 5 (11.6%) |
Infant age at breast milk sampling (days) | 176 [38–494] | 162 [31–493] |
Breastfeeding type until sampling | ||
EBFa | 20 (50.0%) | 17 (39.5%) |
MBFb | 12 (30.0%) | 18 (41.9%) |
Unknown | 8 (20.0%) | 8 (18.6%) |
Breastfeeding type during the past 15 days before sampling | ||
EBFa | 24 (60.0%) | 25 (58.1%) |
MBFb | 16 (40.0%) | 18 (41.9%) |
Sub-clinical mastitis in at least 1 sample (Na/K > 1) | 15 (37.5%) | 10 (23.3%) |
Postnatal CD4-cell count (per μL)c | 595 [78–2473] | – |
Postnatal plasma HIV viral load (copies/mL)c | 5300 [25–110,000] | – |